Page 2 1 Todos los derechos reservados Rev. Chil. Psiquiatr ...

Vanelle JM, Pere JJ, Giguere M, et al.2001. A double-blind comparative studyof clozapine and risperidone in themanagement of severe chronic schizophrenia.Am J Psychiatry 158:1305–1313.59. Kane JM, Meltzer HY, Carson WH, Jr.,McQuade RD, Marcus RN, Sanchez R.2007c. Aripiprazole for treatment-resistantschizophrenia: results of a multicenter,randomized, double- blind,comparison study versus perphenazine.J Clin Psychiatry 68:213–223.60. Duggal HS, Mendhekar DN. 2006.High-dose aripiprazole in treatmentresistantschizophrenia. J Clin Psychiatry67:674– 67561. Emsley RA, Raniwalla J, Bailey PJ, JonesAM. 2000. A comparison of theeffects of quetiapine (‘seroquel’) andhaloperidol in schizophrenic patientswith a history of and a demonstrated,partial response to conventionalantipsychotic treatment. PRIZE StudyGroup. Int Clin Psychopharmacol15:121–131.62. Boggs DL, Kelly DL, Feldman S, Mc-Mahon RP, Nelson MW, Yu Y, ConleyRR. Quetiapine at high doses for thetreatment of refractory schizophrenia.Schizophr Res. 2008 April; 101(1-3):347–348.63. Sacchetti E, Galluzzo A, ValsecchiP, Romeo F, Gorini B, WarringtonL. 2009. Ziprasidone vs clozapine inschizophrenia patients refractory tomultiple antipsychotic treatments:the MOZART study. Schizophr Res113:112–121.64. Cipriani A, Boso M, Barbui C. 2009.Clozapine combined with differentantipsychotic drugs for treatment resistantschizophrenia. Cochrane DatabaseSyst Rev: CD006324.65. Correll CU, Rummel-Kluge C, CorvesC, Kane JM, Leucht S. 2009. Antipsychoticcombinations vs monotherapyin schizophrenia: a meta-analysisof randomized controlled trials. SchizophrBull 35:443–457.66. Wang J, Omori IM, Fenton M, SoaresB. Sulpiride augmentation for schizophrenia.Cochrane Database Syst Rev.2010;1:CD008125. PMID: 20091661.67. Bachmann CJ, Lehr D, Theisen FM, etal. Aripiprazole as an adjunct to clozapinetherapy in adolescents with earlyonsetschizophrenia: a retrospectivechartreview. Pharmacopsychiatry2009;42(4):153–7.68. Chang JS, Ahn YM, Park HJ, Lee KY,Kim SH, Kang UG, et al. 2008. Aripiprazoleaugmentation in clozapinetreatedpatients with refractory schizophrenia:an 8-week, randomized,double- blind, placebo-controlledtrial. J Clin Psychiatry 69:720–731.68. Fleischhacker WW, Heikkinen ME,Olie JP, Landsberg W, Dewaele P,McQuade RD, et al. 2010. Effects ofadjunctive treatment with aripiprazoleon body weight and clinical efficacyin schizophrenia patients treatedwith clozapine: a randomized, doubleblind,placebo-controlled trial. Int JNeuropsychophar- macol 13:1115–1125.69. Tiihonen J, Hallikainen T, RyynanenOP, Repo-Tiihonen E, Koti- lainen I,Eronen M, et al. 2003. Lamotrigine intreatment- resistant schizophrenia: arandomized placebo-controlled crossovertrial. Biol Psychiatry 54:1241–1248.70. Englisch S, Esser A, Enning F, HohmannS, Schanz H, Zink M. 2010.Augmentation with pregabalin in schizophrenia.J Clin Psychopharmacol30:437–440.71. Whitehead C, Moss S, Cardno A,Lewis G. Antidepressants for peoplewith both schizophrenia and depression.Cochrane Database Syst Rev.2002;(2):CD002305.72. Rummel-Kluge C, Kissling W, LeuchtS. Antidepressants for the negativesymptoms of schizophrenia. CochraneDatabase Syst Rev. 2006 Jul19;(3):CD005581.73. Stenberg JH, Terevnikov V, Joffe M,Tiihonen J, Tchoukhine E, BurkinM, et al. More evidence on proneurocognitiveeffects of add-on mirtazapinein schizophrenia. Progr Neu-72 Rev. Chil. Psiquiatr. Neurol. Infanc. Adolesc. / Volumen 24, Nº 1, Marzo 2103 Todos los derechos reservados